# US 6,727,271 B2 · Substituted acid derivatives useful as antidiabetic and antiobesity agents and method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,271 B2
- Document ID: US6727271B2
- Status: Granted
- Kind: B2
- Application number: 10/081,075
- Filed: 2002-02-22
- Published: 2003-05-08
- Granted: 2004-04-27
- Earliest claimed: 1999-09-22
- Assignees: Bristol-Myers Squibb Company
- Inventors: Peter T. Cheng; Pratik Devasthale; Yoon Jeon; Sean Chen; Hao Zhang
- Web page: https://patentgrep.com/patent/US6727271B2

## CPC

- C07D 263/58: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D 231/12: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 233/56: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D 249/08: 1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D 263/32: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 277/24: Radicals substituted by oxygen atoms
- C07D 413/12: linked by a chain containing hetero atoms as chain links
- C07D 413/14: containing three or more hetero rings
- C07D 417/04: directly linked by a ring-member-to-ring-member bond
- C07D 417/12: linked by a chain containing hetero atoms as chain links
- C07D 495/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Compounds are provided which have the structure wherein Q is C or N, A is O or S, Z is O or a bond, X is CH or N and R1, R2, R2a, R2b, R2c, R3, Y, x, m, and n are as defined herein, which compounds are useful as antidiabetic, hypolipidemic, and antiobesity agents.

## Claims

### Claim 1

A method for lowering blood glucose levels or for treating diabetes, or a dysplastic disease, which comprises administering to a patient in need of treatment a therapeutically effective amount of a compound which has the structure
wherein x is 1,2,3 or 4; m is 1 or 2; n is 1 or 2;
Q is C;
A is O;
Z is O;
R1 is H or lower alkyl;
X is CH;
R2 is H or alkyl;
R2a, R2b and R2c are the same or different and are selected from H or alkyl;
R3 is aryloxycarbonyl, alkyloxycarbonyl, alkynyloxycarbonyl, alkenyloxycarbonyl, alkoxyaryloxycarbonyl, arylalkyloxycarbonyl, alkylaryloxycarbonyl, alkynyloxycarbonyl,
Y is CO2R4 where R4 is H or alkyl, or a prodrug ester;
or stereoisomers thereof, a prodrug ester thereof, and a pharmaceutically acceptable salt thereof.

### Claim 2

A method for lowering blood glucose levels or for treating diabetes, which comprises administering to a patient in need of treatment a therapeutically effective amount of a compound which has the structure
where R1 is alkyl,
(CH2)m is CH2 or
and R3 is aryloxycarbonyl or alkoxyaryloxycarbonyl.

### Claim 3 (depends on 2)

The method as defined in claim 2 where in the compound employed (CH2)m is CH2.

### Claim 4 (depends on 1)

The method as defined in claim 1 wherein the compound employed has the structure

### Claim 5 (depends on 1)

The method as defined in claim 1 wherein the compound employed has the structure

### Claim 6 (depends on 1)

The compound as defined in claim 1 where in the compound employed (CH2)x is alkylene, alkenylene, allenyl, or alkynylene.

### Claim 7 (depends on 1)

The method as defined in claim 1 where in the compound employed (CH2)x is CH2, (CH2)2, (CH2)3, or
(CH2)m is CH2, or
(where Ra is alkyl or alkenyl), (CH2)n is CH2, R1 is lower alkyl, R2 is H, R2a is H, R4 is H, and R3 is arylalkyloxycarbonyl, aryloxycarbonyl, alkylaryloxycarbonyl, which may be optionally substituted.

### Claim 8 (depends on 1)

The method as defined in claim 1 where the compound employed has the structure

### Claim 9 (depends on 1)

The method as defined in claim 1 wherein the compound employed has the structure

### Claim 10 (depends on 1)

The method as defined in claim 1 wherein the compound employed has the structure

### Claim 11 (depends on 1)

The method as defined in claim 1 wherein the compound employed has the structure

### Claim 12 (depends on 2)

The method as defined in claim 2 wherein the compound employed has the structure

### Claim 13 (depends on 2)

The method as defined in claim 2 wherein the compound employed has the structure

### Claim 14 (depends on 2)

The method as defined in claim 2 wherein the compound employed has the structure

### Claim 15 (depends on 2)

The method as defined in claim 2 wherein the compound employed has the structure

### Claim 16 (depends on 2)

The method as defined in claim 2 wherein the compound employed has the structure

### Claim 17 (depends on 2)

The method as defined in claim 2 wherein the compound employed has the structure

### Claim 18 (depends on 2)

The method as defined in claim 2 wherein the compound employed has the structure

### Claim 19 (depends on 2)

The method as defined in claim 2 wherein the compound employed has the structure
